Clin2
NCT07001059Possibly a fitRecruiting

Ultrasound to see nerve swelling in giant cell arteritis

Giant Cell Arteritis (GCA)

Part of Brain & nervous system, Heart & circulation, Immune system & allergy, Skin clinical trials.

This trial uses an ultrasound to check for swelling around the optic nerve in people who may have giant cell arteritis (GCA). It aims to see if this test can help diagnose GCA faster.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
190 people
Ages
50 years and older
Study type
Interventional

Who can take part

  • You are over 50 years old
  • Your doctor thinks you might have giant cell arteritis (GCA)
  • You have not had GCA before
  • You have not had polymyalgia rheumatic (PMR) without a PET scan
  • You do not have certain eye or nerve conditions (like retinal disease, multiple sclerosis, or high pressure in the brain)
  • Have not taken more than 0.5 mg per kilogram of steroids (cortisone-like drugs) in the last 2 weeks

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07246577Recruiting
Improving diagnosis and monitoring in giant cell arteritis

This study uses ultrasound, a biopsy of the temple artery, and blood tests to improve how giant cell arteritis (GCA) is diagnosed, monitored, and predicted. It may help doctors find better ways to manage this condition.

Gothenburg
NCT07206238Recruiting
Orbital blood vessel inflammation in optic nerve disease

This study uses MRI scans to look at inflammation in blood vessels around the eye in two conditions: giant cell arteritis (GCA, a type of blood vessel inflammation) and ischemic optic neuropathy (a condition where the optic nerve doesn't get enough blood). The goal is to better understand how inflammation affects the optic nerve and vision, which could help guide future treatments.

Glostrup Municipality
NCT06742671Recruiting
Fast-track pathway for giant cell arteritis diagnosis

This trial tests a fast-track process to quickly diagnose giant cell arteritis (GCA), a condition that causes blood vessel inflammation. It may help patients get the right care faster.

La Rochelle
NCT06957002Not yet recruiting· Phase 2
Bosentan for giant cell arteritis

This trial tests whether a drug called bosentan, which is usually used for other conditions, can help calm the inflammation in giant cell arteritis and reduce symptoms. You would take it in addition to your usual treatment, and it might help lower the dose of steroids you need.

Paris
NCT07060274Recruiting
How fast does the halo sign vanish after steroids in GCA?

This trial is for people newly diagnosed with giant cell arteritis (GCA) who have a 'halo' sign on their temporal artery ultrasound. It will study how quickly the halo disappears after starting steroid treatment, helping doctors understand the best way to use steroids for this condition.

Le Mans, Sarthe
NCT07269938Not yet recruiting
B-cell study for giant cell arteritis and related conditions

This study looks at immune cells called B-cells in people with giant cell arteritis (a condition causing inflammation in blood vessels) and other immune disorders, to see if targeting these cells could be a new treatment. It involves imaging and blood tests.

Edinburgh, City Of Edinburgh

Hear when a new Giant Cell Arteritis (GCA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.